PHARMACOKINETICS OF MORPHINE INFUSION IN PREMATURE NEONATES

被引:45
作者
HARTLEY, R
GREEN, M
QUINN, M
LEVENE, MI
机构
来源
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION | 1993年 / 69卷 / 01期
关键词
D O I
10.1136/adc.69.1_Spec_No.55
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Morphine pharmacokinetics were studied in 17 premature neonates (26-34 weeks' gestation) after intravenous infusion during the first 24 hours of life. Infants received either standard dose morphine that comprised of a 100 mug/kg/hour loading infusion for 2 hours followed by a maintenance infusion of 12.5 mug/kg/hour, or a high dose of 200 mug/kg/hour for 2 hours followed by 50 mug/kg/hour. Mean plasma concentrations of morphine (SD) after 2 and 24 hours were 99 (12.9) and 96.4 (3.2) ng/ml, and 184.2 (37.7) and 319 (71.2) ng/ml for the standard and high dose regimens, respectively. Morphine-3-glucuronide plasma concentrations achieved about 20% and 80% of morphine values at 2 and 24 hours respectively. Morphine-6-glucuronide could not be detected at 2 hours, but attained 20-25% of morphine plasma concentrations by 24 hours. The population mean morphine clearance was 2.4 ml/min/kg, the elimination half life was 8.75 hours and the volume of distribution was 1.82 l/kg. High plasma concentrations of morphine appeared to be well tolerated. Although mean arterial blood pressure decreased during the first six hours of treatment, this was not statistically significant; two infants experienced transient muscle rigidity, but no evidence of seizures was noted. There appears to be no clinical advantage in using the high dose regimen.
引用
收藏
页码:55 / 58
页数:4
相关论文
共 20 条
[1]   MORPHINE KINETICS AFTER DIAMORPHINE INFUSION IN PREMATURE NEONATES [J].
BARRETT, DA ;
ELIASJONES, AC ;
RUTTER, N ;
SHAW, PN ;
DAVIS, SS .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 32 (01) :31-37
[2]   PHARMACOKINETICS OF A SINGLE DOSE OF MORPHINE IN PRETERM INFANTS DURING THE 1ST WEEK OF LIFE [J].
BHAT, R ;
CHARI, G ;
GULATI, A ;
ALDANA, O ;
VELAMATI, R ;
BHARGAVA, H .
JOURNAL OF PEDIATRICS, 1990, 117 (03) :477-481
[3]   MORPHINE-METABOLISM IN CHILDREN [J].
CHOONARA, IA ;
MCKAY, P ;
HAIN, R ;
RANE, A .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 28 (05) :599-604
[4]  
DAHLSTROM B, 1979, CLIN PHARMACOL THER, V26, P354
[5]   DIAMORPHINE INFUSION IN THE PRETERM NEONATE [J].
ELIASJONES, AC ;
BARRETT, DA ;
RUTTER, N ;
SHAW, PN ;
DAVIS, SS .
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1991, 66 (10) :1155-1157
[6]   ANTINOCICEPTIVE AND VENTILATORY EFFECTS OF THE MORPHINE METABOLITES - MORPHINE-6-GLUCURONIDE AND MORPHINE-3-GLUCURONIDE [J].
GONG, QL ;
HEDNER, T ;
HEDNER, J ;
BJORKMAN, R ;
NORDBERG, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 193 (01) :47-56
[7]  
GREENOUGH A, 1984, LANCET, V1, P1
[8]   ANALYSIS OF MORPHINE AND ITS 3-GLUCURONIDES AND 6-GLUCURONIDES BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUOROMETRIC DETECTION FOLLOWING SOLID-PHASE EXTRACTION FROM NEONATAL PLASMA [J].
HARTLEY, R ;
GREEN, M ;
QUINN, M ;
LEVENE, MI .
BIOMEDICAL CHROMATOGRAPHY, 1993, 7 (01) :34-37
[9]   LONG LASTING RESPIRATORY DEPRESSION INDUCED BY MORPHINE-6-GLUCURONIDE [J].
HASSELSTROM, J ;
BERG, U ;
LOFGREN, A ;
SAWE, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 27 (04) :515-518
[10]   POSTOPERATIVE MORPHINE INFUSION IN NEWBORN-INFANTS - ASSESSMENT OF DISPOSITION CHARACTERISTICS AND SAFETY [J].
KOREN, G ;
BUTT, W ;
CHINYANGA, H ;
SOLDIN, S ;
TAN, YK ;
PAPE, K .
JOURNAL OF PEDIATRICS, 1985, 107 (06) :963-967